FABP2 and colorectal carcinoma: The Ala/Thr, Thr/Thr, and Ala/Thr+Thr/Thr genotypes for FABP2 rs1799883 did not increase CRC risk, with the Ala/Ala genotype as reference (OR = 0.893, 95% CI 0.656–1.216; OR = 0.909, 95% CI 0.526–1.570; and OR = 0.899, 95% CI 0.672–1.201, respectively).